These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25034148)

  • 21. Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?
    Chaudhary L; Kharfan-Dabaja MA; Hari P; Hamadani M
    Bone Marrow Transplant; 2013 Nov; 48(12):1489-96. PubMed ID: 23584438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.
    Cowan AJ; Stevenson PA; Cassaday RD; Graf SA; Fromm JR; Wu D; Holmberg LA; Till BG; Chauncey TR; Smith SD; Philip M; Orozco JJ; Shustov AR; Green DJ; Libby EN; Bensinger WI; Shadman M; Maloney DG; Press OW; Gopal AK
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):380-385. PubMed ID: 26348890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Follicular lymphoma: first - line selection criteria of treatment].
    Nesterova ES; Kravchenko SK; Kovrigina AM; Gemdzhian EG; Plastinina LV; Babaeva FE; Obukhova TN; Magomedova AU; Gaponova TV; Kremenetskaya AM; Vorobyev AI
    Ter Arkh; 2019 Aug; 91(8):75-83. PubMed ID: 32598757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
    Tomblyn MR; Ewell M; Bredeson C; Kahl BS; Goodman SA; Horowitz MM; Vose JM; Negrin RS; Laport GG
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1051-7. PubMed ID: 21073974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party.
    Robinson SP; Boumendil A; Finel H; Blaise D; Poiré X; Nicolas-Virelizier E; Or R; Malladi R; Corby A; Fornecker L; Caballero D; Pohlreich D; Nagler A; Thieblemont C; Finke J; Bachy E; Vincent L; Schroyens W; Schouten H; Dreger P
    Bone Marrow Transplant; 2016 Mar; 51(3):365-71. PubMed ID: 26618550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation.
    Cook G; Smith GM; Kirkland K; Lee J; Pearce R; Thomson K; Morris E; Orchard K; Rule S; Russell N; Craddock C; Marks DI;
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1419-27. PubMed ID: 20399879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma.
    Bhella S; Varela NP; Aw A; Bredeson C; Cheung M; Crump M; Fraser G; Sajkowski S; Kouroukis T
    Curr Oncol; 2020 Dec; 27(6):e632-e644. PubMed ID: 33380879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation.
    Eyre TA; Barrington SF; Okosun J; Abamba C; Pearce RM; Lee J; Carpenter B; Crawley CR; Bloor AJC; Gilleece M; Nicholson E; Shah N; Orchard K; Malladi R; Townsend WM
    Haematologica; 2023 Mar; 108(3):785-796. PubMed ID: 35586966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.
    Rule S; Cook G; Russell NH; Hunter A; Robinson S; Morley N; Sureda A; Patrick P; Clifton-Hadley L; Adedayo T; Kirkwood A; Peggs KS
    Br J Haematol; 2019 Mar; 184(6):999-1005. PubMed ID: 30560573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma.
    Tam CS; Khouri IF
    Leuk Lymphoma; 2009 Aug; 50(8):1239-48. PubMed ID: 19562639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party.
    Robinson SP; Boumendil A; Finel H; Peggs KS; Chevallier P; Sierra J; Finke J; Poiré X; Maillard N; Milpied N; Yakoub-Agha I; Koh M; Kröger N; Nagler A; Koc Y; Dietrich S; Montoto S; Dreger P
    Bone Marrow Transplant; 2018 May; 53(5):617-624. PubMed ID: 29335632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to Approach a Hodgkin Lymphoma Patient With Relapse After Autologous SCT: Allogeneic SCT.
    Mei M; Chen R
    Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):26-33. PubMed ID: 29233742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma.
    Bhatt VR; Armitage JO
    Expert Opin Biol Ther; 2016; 16(1):57-66. PubMed ID: 26515478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma.
    Borgerding A; Hasenkamp J; Glass B; Wulf G; Trümper L
    Ann Hematol; 2010 Mar; 89(3):283-9. PubMed ID: 19727725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation.
    Shanbhag S; Smith MR; Emmons RV
    Stem Cells Cloning; 2010 Jul; 3():93-102. PubMed ID: 24198514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of allogeneic stem cell transplantation in mantle cell lymphoma.
    Cohen JB; Burns LJ; Bachanova V
    Eur J Haematol; 2015 Apr; 94(4):290-7. PubMed ID: 25154430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC.
    Tessoulin B; Ceballos P; Chevallier P; Blaise D; Tournilhac O; Gauthier J; Maillard N; Tabrizi R; Choquet S; Carras S; Ifrah N; Guillerm G; Mohty M; Tilly H; Socie G; Cornillon J; Hermine O; Daguindau É; Bachy E; Girault S; Marchand T; Oberic L; Reman O; Leux C; Le Gouill S
    Bone Marrow Transplant; 2016 Sep; 51(9):1184-90. PubMed ID: 27111043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.
    Avivi I; Boumendil A; Finel H; Nagler A; de Sousa AB; Santasusana JMR; Vandenberghe E; Afanasyev B; Bordessoule D; Moraleda JM; Garcia EC; Pohlreich D; Garcia GG; Thomson K; Or R; Beelen D; Zuffa E; Giebel S; Berthou C; Salles G; Melpignano A; Montoto S; Dreger P
    Bone Marrow Transplant; 2018 Aug; 53(8):1001-1009. PubMed ID: 29463854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.
    Delarue R; Haioun C; Ribrag V; Brice P; Delmer A; Tilly H; Salles G; Van Hoof A; Casasnovas O; Brousse N; Lefrere F; Hermine O;
    Blood; 2013 Jan; 121(1):48-53. PubMed ID: 22718839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation.
    Cwynarski K; van Biezen A; de Wreede L; Stilgenbauer S; Bunjes D; Metzner B; Koza V; Mohty M; Remes K; Russell N; Nagler A; Scholten M; de Witte T; Sureda A; Dreger P
    J Clin Oncol; 2012 Jun; 30(18):2211-7. PubMed ID: 22547610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.